POTEE
POTEE (POTE ankyrin domain family member E) is a member of the POTE ankyrin domain containing gene group and is also known as POTE2, POTE-2, A26C1, POTE2gamma, CT104.2 and A26C1A. It is predicted to bind protein kinases and to contribute to the postsynaptic actin cytoskeleton. Browse Assay Genie's current range of POTEE research reagents below, or read on for the biology behind the target.
POTEE is a protein-coding gene whose product has not been fully characterised experimentally, and UniProt does not currently provide a curated function annotation for it. The NCBI Gene summary, which draws on the Alliance of Genome Resources, describes POTEE as predicted to enable protein kinase binding activity and to be a structural constituent of the postsynaptic actin cytoskeleton. These are predictions, so researchers working with the POTEE protein should treat them as hypotheses to test rather than established mechanisms.
The POTEE gene belongs to the HGNC gene group of POTE ankyrin domain containing genes. UniProt notes that the C-terminal section of the protein belongs to the actin family, which fits the predicted link to the actin cytoskeleton. The same summary reports that POTEE is involved in substantia nigra development and has been located in blood microparticles and extracellular exosomes. It was also previously located in what is now an obsolete extracellular space term. UniProt does not annotate a subcellular location for the protein.
The gene has gone by several names. Earlier symbols and aliases include POTE2, POTE-2, A26C1, POTE2gamma, CT104.2 and A26C1A. Previous names were ANKRD26-like family C, member 1A, and POTE ankyrin domain family, member E. This history reflects the gene's membership of a family of related ankyrin repeat genes. It is worth checking which alias a publication or reagent description uses, because family members can be easy to confuse when searching the literature or designing an experiment, for example when planning a POTEE antibody or POTEE ELISA kit study.
POTEE is predicted to be a structural constituent of the postsynaptic actin cytoskeleton and carries a C-terminal region belonging to the actin family.
The NCBI Gene summary links POTEE to substantia nigra development, making it of interest for studies of midbrain development.
POTEE has been located in extracellular exosomes and blood microparticles, relevant to work on vesicle-associated proteins.
POTEE is predicted to enable protein kinase binding activity, a prediction that invites experimental testing of its interaction partners.
The function of POTEE is not fully established. NCBI Gene describes it as predicted to enable protein kinase binding and to be a structural constituent of the postsynaptic actin cytoskeleton. It is also reported to be involved in substantia nigra development.
POTEE is also called POTE2, POTE-2, A26C1, POTE2gamma, CT104.2 and A26C1A. Earlier names include ANKRD26-like family C, member 1A, and POTE ankyrin domain family, member E. The HGNC full name is POTE ankyrin domain family member E.
HGNC places POTEE in the POTE ankyrin domain containing gene group. UniProt also notes that the C-terminal section of the protein belongs to the actin family. Mouse and rat orthologs are not specified in the supplied data.
Other POTE ankyrin domain family members and actin cytoskeleton proteins may be listed as pages become available.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6S8J3; product specifications from Assay Genie datasheets.